Cargando…

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis

Detalles Bibliográficos
Autores principales:	Grace, Josephine A., Casey, Stephen, Burrell, Louise M., Angus, Peter W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471588/ https://www.ncbi.nlm.nih.gov/pubmed/32886332 http://dx.doi.org/10.1007/s12072-020-10084-4

Ejemplares similares

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
por: Shailesh, F. N. U., et al.
Publicado: (2014)

Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis
por: Guo, Gaoyue, et al.
Publicado: (2022)

Decompensated primary hypoparathyroidism in a patient with COVID-19
por: Bonnet, Jean-Baptiste, et al.
Publicado: (2021)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Iavarone, Massimo, et al.
Publicado: (2020)

Letter regarding “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Medhat, Mohammed A., et al.
Publicado: (2020)

Impact of COVID-19 on Patients with Decompensated Liver Cirrhosis
por: Moga, Tudor Voicu, et al.
Publicado: (2023)

More efforts to explore the association between cirrhosis and COVID-19 mortality, and the association between NAFLD and severe COVID-19
por: Li, Zheng, et al.
Publicado: (2022)

Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
por: Horn, Paul, et al.
Publicado: (2018)

Respiratory decompensation with proning – when prone positioning can worsen respiratory mechanics
por: Oydanich, Marko, et al.
Publicado: (2022)

Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data
por: Wang, Ying, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study
por: Tapper, Elliot B., et al.
Publicado: (2019)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis
por: Jo, Sang Kyung, et al.
Publicado: (2019)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19
por: Esam, Zohreh
Publicado: (2020)

Reply to Comments on Relationship between Hypoalbuminemia on Admission and Long-term Mortality in Patients with Acute Decompensated Heart Failure
por: Yatsu, Shoichiro, et al.
Publicado: (2019)

Hypoalbuminemia in Patients with Acute Decompensated Heart Failure
por: Imamura, Teruhiko
Publicado: (2019)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022)

Post RNA-based COVID vaccines myocarditis: Proposed mechanisms
por: Kadkhoda, Kamran
Publicado: (2022)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

DSEK for corneal decompensation post bee sting injury
por: Joshi, Pallavi, et al.
Publicado: (2022)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis
por: John, Binu V., et al.
Publicado: (2021)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis
por: VoPham, Trang, et al.
Publicado: (2023)

Tu1260: IMPACT OF COVID-19 ON PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
por: Moga, Tudor V., et al.
Publicado: (2022)

Reductions in liver cirrhosis hospitalizations during the COVID-19 pandemic
por: Li, Jianglei, et al.
Publicado: (2021)

Increased Cardiovascular Mortality in Ecuador during COVID-19 Pandemic
por: Fornasini, Marco, et al.
Publicado: (2023)

Anti-NMDA-R encephalitis post-COVID-19: Case report and proposed physiopathologic mechanism
por: Sanchez-Larsen, A., et al.
Publicado: (2022)

Cirrhosis management in a major referral center during COVID-19
por: Garrido, Isabel, et al.
Publicado: (2020)

Predicting 1-year mortality among patients with decompensated cirrhosis: results of a multicentre evaluation of the Bristol Prognostic Score
por: Bowers, Sarah Pauline, et al.
Publicado: (2022)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eum8cjti7tti5gsub7nbglk26m